| Entry |
|
|---|
| Name |
Xanomeline (USAN)
|
|---|
| Formula |
C14H23N3OS
|
|---|
| Exact mass |
281.1562
|
|---|
| Mol weight |
281.4169
|
|---|
| Structure |
     |
|---|
| Activity |
Alzheimer's disease treatment [cholinergic agent]
|
|---|
| Remark |
|
|---|
| Target |
|
|---|
| Pathway |
|
|---|
| Interaction |
|
|---|
| Structure map |
| Cholinergic and anticholinergic drugs |
|
|---|
| Brite |
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Acetylcholine (muscarinic)
muscarinic cholinergic receptor M1 [HSA:1128] [KO:K04129]
Xanomeline
D06330 Xanomeline (USAN)
muscarinic cholinergic receptor M4 [HSA:1132] [KO:K04132]
Xanomeline
D06330 Xanomeline (USAN)
 |
|---|
| Other DBs |
CAS: 131986-45-3 PubChem: LigandBox: NIKKAJI: |
|---|
| KCF data |
ATOM 19
1 C8y C 13.3700 -7.3500
2 C8y C 14.7700 -7.3500
3 N5x N 15.2026 -6.0185
4 S2x S 14.0700 -5.1956
5 N5x N 12.9374 -6.0185
6 O2a O 12.6700 -8.5624
7 C2y C 15.4700 -8.5624
8 C1x C 15.4700 -9.9624
9 N1y N 16.6824 -10.6624
10 C1x C 17.8949 -9.9624
11 C1x C 17.8949 -8.5624
12 C2x C 16.6824 -7.8624
13 C1b C 11.4576 -7.8400
14 C1b C 10.2451 -8.5400
15 C1b C 9.0327 -7.8400
16 C1b C 7.8203 -8.5400
17 C1b C 6.6078 -7.8400
18 C1a C 5.3954 -8.5400
19 C1a C 16.6821 -12.0398
BOND 20
1 1 2 1
2 2 3 2
3 3 4 1
4 4 5 1
5 1 5 2
6 1 6 1
7 2 7 1
8 7 8 1
9 8 9 1
10 9 10 1
11 10 11 1
12 11 12 1
13 7 12 2
14 6 13 1
15 13 14 1
16 14 15 1
17 15 16 1
18 16 17 1
19 17 18 1
20 9 19 1
|
|---|
